Company Arca Biopharma Inc Nasdaq
Equities
US00211Y4070
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Thomas Keuer
CEO | Chief Executive Officer | 65 | 01/06/01 |
C. Dekker
DFI | Director of Finance/CFO | 60 | 10/21/10 |
Sharon Perry
LAW | General Counsel | - | 01/08/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Anders Hove
BRD | Director/Board Member | 58 | 16/17/16 |
Robert Conway
CHM | Chairman | 70 | 03/13/03 |
Linda Grais
BRD | Director/Board Member | 68 | 01/07/01 |
Jacob Ma-Weaver
BRD | Director/Board Member | 37 | 15/22/15 |
James Flynn
BRD | Director/Board Member | 43 | 15/22/15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 14,507,143 | 14,320,024 ( 98.71 %) | 0 | 98.71 % |
Company contact information
ARCA biopharma, Inc.
10170 Church Ranch Way Suite 100
80021, Westminster
+720 940 2200
http://www.arcabio.comSector
1st Jan change | Capi. | |
---|---|---|
+20.17% | 126B | |
+24.67% | 118B | |
+23.58% | 27.87B | |
-17.74% | 20.95B | |
-16.45% | 16.92B | |
-15.21% | 16.18B | |
+11.91% | 14.84B | |
-47.10% | 14.79B | |
+54.50% | 14.08B |